The health-affordability action applies a 30% trade-margin ceiling from November 9 across treatments used for more than 20 cancer types.

IMPORTANT INTELLIGENCE · ₹99 / ₹199

THE INVESTOR ANALYSIS CONTINUES BEHIND THE GRID.

Unlock the full analysis, investor takeaways, risk map, watch points and source record with IMG Premium. The ₹199 plan also includes Grid Minds, Investor Lens podcasts, In Brief and the daily morning and evening PDFs.

Continue to membership in your browser ↗Informational research only. No personalised recommendation or assured-return claim.